country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-187622

Copy Link Print Information

Org 33201

Org 33201 is an orally active and selective Aromatase inhibitor with an IC₅₀ of 2.2 nM. Org 33201 inhibits the activity of Aromatase by binding to its heme iron. Org 33201 can be used in the study of estrogen-dependent diseases (such as postmenopausal breast cancer).

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 148714-92-5
Formel: C₂₁H₂₉ClN₂S
Molecular Weight:376.99

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

Org 33201 Chemical Structure

CAS. Nr.: 148714-92-5

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

IC₅₀ & Target

^[1]

Aromatase

2.2 nM (IC₅₀)

Alle Cytochrome P450 Isoform-spezifische Produkte anzeigen :

In Vitro

Org 33201 potently inhibits aromatase activity in human placental microsomes, with an IC₅₀ of 2.2 nM, and acts as a competitive inhibitor by binding to heme iron^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Org 33201 (0.5-1 mg/kg; p.o.; single dose) reduces plasma estradiol levels in a dose-dependent manner in beagle dogs treated with FSH (HY-NP197)/hCG (HY-107953)^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Chemical Information

CAS. Nr. 148714-92-5
Molecular Weight 376.99
Formel C₂₁H₂₉ClN₂S
SMILES

C(C)[C@@]12C=3C(=C(SCC)C=CC3CCC1)C[C@@H](CN4C=CN=C4)C2.Cl
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Handling Instructions (2659 KB)

Verweise

[1]. Kui Lin, et al. Treatment of breast cancer using combination therapies comprising an ATP competitive AKT inhibitor, a CDK4/6 inhibitor, and fulvestrant. WO2021030248A1. WIPO. 2021-02-18.

[2]. Vanden Bossche HV, et al. Aromatase inhibitors--mechanisms for non-steroidal inhibitors. Breast cancer research and treatment. 1994;30(1):43-55.

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen